LEIGH CHILDRESS: Open Payments
NPI 1700104189 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$61,197 in 128 payments from 25 companies in 2025. Trend: 2023 $59,757 · 2024 $63,400 · 2025 $61,197
Speaker / faculty: $50,550Travel & lodging: $5,891Food & beverage: $4,406Consulting: $350
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 74 | $53,291 |
| Daiichi Sankyo Inc. | 8 | $3,143 |
| Amgen Inc. | 8 | $2,609 |
| Janssen Scientific Affairs, LLC | 7 | $480 |
| BeiGene USA, Inc. | 1 | $350 |
| Genentech USA, Inc. | 1 | $210 |
| Kite Pharma, Inc. | 1 | $149 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 6 | $125 |
| Blueprint Medicines Corporation | 1 | $118 |
Products named: DATROWAY, LYNPARZA, KYPROLIS, CALQUENCE, BRUKINSA, IMFINZI, ERLEADA, Lunsumio.
Industry payments across AL — which companies pay providers there.
